<HashMap><database>EGA</database><scores/><additional><omics_type>Genomics</omics_type><contact_person>Roeland Verhaak</contact_person><full_dataset_link>https://ega-archive.org/dacs/EGAC00001000268</full_dataset_link><host>EGA</host><description>EGA DAC EGAC00001000268</description><repository>EGA</repository><email>roel.verhaak@jax.org</email><pubmed_abstract>Glioblastoma (GBM) is a prototypical heterogeneous brain tumor refractory to conventional therapy. A small residual population of cells escapes surgery and chemoradiation, resulting in a typically fatal tumor recurrence ∼ 7 mo after diagnosis. Understanding the molecular architecture of this residual population is critical for the development of successful therapies. We used whole-genome sequencing and whole-exome sequencing of multiple sectors from primary and paired recurrent GBM tumors to reconstruct the genomic profile of residual, therapy resistant tumor initiating cells. We found that genetic alteration of the p53 pathway is a primary molecular event predictive of a high number of subclonal mutations in glioblastoma. The genomic road leading to recurrence is highly idiosyncratic but can be broadly classified into linear recurrences that share extensive genetic similarity with the primary tumor and can be directly traced to one of its specific sectors, and divergent recurrences that share few genetic alterations with the primary tumor and originate from cells that branched off early during tumorigenesis. Our study provides mechanistic insights into how genetic alterations in primary tumors impact the ensuing evolution of tumor cells and the emergence of subclonal heterogeneity.</pubmed_abstract><pubmed_title>Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution.</pubmed_title><pubmed_authors>Kim Hoon H, Zheng Siyuan S, Amini Seyed S SS, Virk Selene M SM, Mikkelsen Tom T, Brat Daniel J DJ, Grimsby Jonna J, Sougnez Carrie C, Muller Florian F, Hu Jian J, Sloan Andrew E AE, Cohen Mark L ML, Van Meir Erwin G EG, Scarpace Lisa L, Laird Peter W PW, Weinstein John N JN, Lander Eric S ES, Gabriel Stacey S, Getz Gad G, Meyerson Matthew M, Chin Lynda L, Barnholtz-Sloan Jill S JS, Verhaak Roel G W RG</pubmed_authors><name_synonyms>glioblastoma multiforme, GBM, adult glioblastoma multiforme, grade IV adult astrocytic tumour, spongioblastoma multiforme., grade IV adult astrocytic tumor, grade IV adult Astrocytic tumor, primary glioblastoma multiforme</name_synonyms><pubmed_title_synonyms>Therapy, grade IV adult astrocytic tumour, Complete Exome Sequencings, Malignant Neoplasm, Complete Exome, Neoplasms, Exome, Benign Neoplasm, Giant Cell, Grade IV, Tumor, Astrocytomas, Malignant, adult glioblastoma multiforme, Exome Sequencing, Benign, primary glioblastoma multiforme, Neoplasm, glioblastoma, Whole Transcriptome, Transcriptome Sequencing, Giant Cell Glioblastomas, treatment, glioblastoma multiforme, WES, Complete Transcriptome, Complete, Complete Transcriptome Sequencing, Exome Sequencings, Glioblastoma, grade IV adult astrocytic tumor, Genomes, Malignancy, spongioblastoma multiforme, Complete Exome Sequencing, Whole Transcriptome Sequencing, Glioblastomas, GBM, Benign Neoplasms, whole genome, Cancers, Giant Cell Glioblastoma, Treatments, Sequencing, Astrocytoma, Neoplasias, Glioblastoma Multiforme, Whole Exome, Grade IV Astrocytomas, Therapeutic, grade IV adult Astrocytic tumor, Whole, Whole Exome Sequencing, disease management, Therapies, Treatment, Malignancies, Grade IV Astrocytoma, other neoplasm, Transcriptome Sequencings, Neoplasia, Cancer, Tumors, Malignant Neoplasms.</pubmed_title_synonyms><pubmed_abstract_synonyms>Cognitive Function, dp53, Antemortem Diagnosis, single-organism developmental process, Brain Neoplasms, postnatal development, Stem Cells, growth and development, sci, Tumor, Astrocytomas, Diagnosis, Cancer Stem, betaTub3, Brain Metastases, Tp53, Mutations, School-Age, Readability, DMP53, Neoplastic Colony Forming Units, primary tumour, INTRACRANIAL NEOPL, bbl, symptoms, HOW, How, Whole Transcriptome, Transcriptome Sequencing, Dmp53, Relapses, ramiform, Initiating Cells, tumour of brain, preoperative procedures, Fs(3)Hor, l(3)j5D5, 24B, imprinted and ancient gene protein, treatment, 1323/07, DmelCG2684, brain neoplasms, Genomes, BCC7, Complete Exome Sequencing, Tumor Initiating Cells, Recurrences, Whole Transcriptome Sequencing, beta-Tub6D, dmp53, hypoplasia, stru, Brain Malignant Neoplasms, Primary Brain Tumors, T, DmP53, 1422/04, Oncogeneses, Brain Tumor, ramified, l(3)S053606, Giant Cell Glioblastoma, NTef2, CG10293, Astrocytoma, genetic, Neoplastic Colony-Forming, l(3)j5B5, B3t, DmelCG3401, Cognitions, neoplasm of brain, Brain Neoplasm, Primary Malignant Brain Tumors, Dp53, Functions, Tumor Stem Cell, grade IV adult Astrocytic tumor, Recurrent Brain Tumor, disease management, Therapies, Malignancies, CG17117, Diagnose, p50/tubulin, Tumors, Therapy, Relapse, screening, CG10873, 0904/17, Intracranial Neoplasm, brain neoplasm, Malignant Brain Neoplasms, Brain Benign Neoplasm, Cancer Stem Cell, Exome, familial, Malignant Primary Brain Neoplasms, Primary Brain Neoplasm, Giant Cell, NEOPL BRAIN, Insight, Primary Brain Tumor, Diagnoses, Fs(3)Sz11, 3t, Benign, Brain Benign Neoplasms, Postmortem, Screenings, Colony-Forming Unit, Stem Cell, Recrudescence, SZ1, primary glioblastoma multiforme, School Age, Examinations and Diagnoses, Brain Malignant Neoplasm, Malignant Primary Brain Tumors, bfy, Postmortem Diagnosis, General, Neoplastic, Tub60D, Malignant Brain Neoplasm, HTH, Hth, Diagnoses and Examination, Primary Malignant, Populations, beta-tub, Postmortem Diagnoses, Complete Transcriptome, Glioblastoma, spongioblastoma multiforme, Cancer of the Brain, DmelCG33336, GBM, signs, CG3401, Benign Neoplasms, beta3Tub, beta3TUB, Colony Forming Units, tumor of the Brain, whole genome, Treatments, early, Malignant Neoplasms, Intracranial, DTB3, hth1, neoplasm of the brain, hth2, Grade IV Astrocytomas, brain tumor, Oncogenesis, primary tumor, Horka, Cells, Whole Exome Sequencing, Cancer Stem Cells, P53, CG2684, Tumor Initiating, p44, Fs(3)Horka, bhy, anon-EST:Liang-2.39, inherited genetic, School-Age Population, other neoplasm, E430016J11Rik, Transcriptome Sequencings, CG31325, betaTub, invasive procedures, Brain, beta[[3]]-Tub, Brain Tumors, DmelCG17117, Primary Malignant Brain Neoplasms, Tumorigeneses, p50, Complete Exome, P62, Neoplasms, Primary Brain Neoplasms, Cancer of Brain, Colony-Forming Units, p53, Benign Neoplasm, number, Tumor Stem Cells, Surgery, 143391_i_at, beta3 TU, Grade IV, Malignant, LFS1, Ximpact, Tumor Stem, l(3)05745, Recurrent Brain Tumors, reduced, Recurrent, Mass, Screening, glioblastoma, Cell., DmF2, tiny, Antemortem, anon-EST:Liang-2.13, Giant Cell Glioblastomas, lod, School-Age Populations, study, WES, Complete, Exome Sequencings, grade IV adult astrocytic tumor, Neoplastic Colony-Forming Units, clone 2.13, l(3)s2612, tumour of the Brain, Malignancy, Recrudescences, D.m.BETA-60D, Neoplastic Stem Cell, Diagnoses and Examinations, Population, Tumor Initiating Cell, Sequencing, Cognitive Functions, Neoplasias, Glioblastoma Multiforme, Whole Exome, Trp53, PRIMARY BRAIN NEOPL, Whole, betaTub60C, DmelCG10293, beta3-tubulin, Grade IV Astrocytoma, operative procedures, beta[[3]]-tubulin, TRP53, School Age Population, constitutitional genetic, tumor of brain, NEOPL INTRACRANIAL, Cancer, small, Initiating Cell, beta-Tub60D, Antemortem Diagnoses, grade IV adult astrocytic tumour, Dmbeta3, findings, Dm-HTH, Malignant Neoplasm, Complete Exome Sequencings, Unit, clone 2.39, BETA 60D, Benign Brain Neoplasms, prac, beta3t, beta3-Tub, intraoperative procedures, Primary, qkr, Tumorigenesis, l(3)S090417, Cell, Examination and Diagnoses, impact-a, Xp53, Neoplastic Stem, development, adult glioblastoma multiforme, Insights, Exome Sequencing, peroperative procedures, Mass Screenings, p53/tubulin, KH93F, Units, Neoplasm, Brain Cancers, imprinted and ancient gene protein homolog, IMPACT, beta[[3]] tubulin, Brain Metastase, who, Intracranial Neoplasms, glioblastoma multiforme, CG33336, brain neoplasm (disease), Complete Transcriptome Sequencing, underdeveloped, primary neoplasia, operative therapy, postnatal growth, D-p53, Carcinogeneses, Function, Glioblastomas, beta60C, operations, Dm-P53, l(3)86Ca, Cancers, beta3, Who/How, Understanding, Lds, Cognitive, Brain Cancer, School Age Populations, dtl, Tub, Meis1, Therapeutic, betatub60D, cardinality, perioperative procedures, Neoplastic Colony-Forming Unit, qkr[93F], Benign Brain Neoplasm, Treatment, brain tumour, growth, hereditary, Neoplasia, RWDD5</pubmed_abstract_synonyms></additional><is_claimable>false</is_claimable><name>Verhaak-GBM</name><description>Data Access Committee EGAC00001000268</description><dates><output>2025-1-9</output></dates><accession>EGAC00001000268</accession><cross_references><TAXONOMY>9606</TAXONOMY><pubmed>25650244</pubmed><EGA>EGAS00001001033</EGA><EGA>EGAS00001001878</EGA><EGA>EGAD00010000656</EGA><EGA>EGAD00001001113</EGA><EGA>EGAD00001001112</EGA><EGA>EGAD00001002214</EGA><EGA>EGAD00001002264</EGA><EGA>EGAD00001001109</EGA><EGA>EGAD00001001110</EGA><EGA>EGAD00001001111</EGA><EGA>EGAD00001002219</EGA><EGA>EGAD00010000654</EGA><EGA>EGAD00001002245</EGA></cross_references></HashMap>